Search

Thermo Fisher Scientific Inc

Geschlossen

BrancheGesundheitswesen

573.66 -0.32

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

573.61

Max

577.21

Schlüsselkennzahlen

By Trading Economics

Einkommen

85M

1.7B

Verkäufe

989M

12B

KGV

Branchendurchschnitt

30.575

64.641

EPS

6.03

Dividendenrendite

0.15

Gewinnspanne

14.516

Angestellte

125,000

EBITDA

262M

2.6B

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+6.98% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

0.15%

2.31%

Nächstes Ergebnis

21. Okt. 2026

Nächste Dividendenausschüttung

15. Okt. 2026

Nächstes Ex-Dividendendatum

15. Sept. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

17B

213B

Vorheriger Eröffnungskurs

573.98

Vorheriger Schlusskurs

573.66

Nachrichtenstimmung

By Acuity

39%

61%

103 / 340 Ranking in Healthcare

Thermo Fisher Scientific Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Aug. 2026, 00:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours, reflecting a decline during the session despite being above the 20-day moving average.

31. Juli 2026, 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

30. Juli 2026, 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

29. Juli 2026, 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

28. Juli 2026, 18:06 UTC

News
Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

27. Juli 2026, 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

24. Juli 2026, 19:23 UTC

News
Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

23. Juli 2026, 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

22. Juli 2026, 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

21. Juli 2026, 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

20. Juli 2026, 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Peer-Vergleich

Kursveränderung

Thermo Fisher Scientific Inc Prognose

Kursziel

By TipRanks

6.98% Vorteil

12-Monats-Prognose

Durchschnitt 614.41 USD  6.98%

Hoch 690 USD

Tief 520 USD

Basierend auf 19 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Thermo Fisher Scientific Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

19 ratings

14

Buy

5

Halten

0

Sell

Stimmung

By Acuity

103 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat